Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

1,540 studies for “Johnson & Johnson”

Pilot Study of Biopsy Scanner for Evaluation of Bronchoscopic Small Biopsy Specimens to Determine AdequacyCompleted
NCT05393154N/AUpdated Aug 18, 2026
Sponsor: Aquyre Bioscience, Inc
Lung Cancer
United States
Durham Connects RCT EvaluationActive Not Recruiting
NCT01406184NAUpdated Aug 18, 2026
Sponsor: Duke University
Unspecified Child Maltreatment, Suspected · Unspecified Child Maltreatment, Confirmed
United States
Pediatric Parental Feeding Video Education ProgramCompleted
NCT07768774NAUpdated Aug 17, 2026
Sponsor: Johnson & Wales University
Feeding Behavior
United States
A Study of Teclistamab and Mezigdomide in People With Multiple MyelomaRecruiting
NCT07105059Phase 1Updated Aug 17, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
Multiple Myeloma
United States
Clinical Evaluation of Two Cosmetic Contact LensesCompleted
NCT06864858NAUpdated Aug 14, 2026
Sponsor: Johnson & Johnson Vision Care, Inc.
Visual Acuity
United States
Objective Assessment of Intraocular Lens Tilt and DecentrationCompleted
NCT07324200N/AUpdated Aug 12, 2026
Sponsor: Johnson & Johnson Surgical Vision, Inc.
Tilt and Decentration
United States
Clinical Investigation of the TECNIS® Next-Generation Intraocular Lens, Model DEN00VTerminated
NCT05574959NAUpdated Aug 11, 2026
Sponsor: Johnson & Johnson Surgical Vision, Inc.
Cataracts
United States
A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).Recruiting
NCT07638683Phase 2Updated Aug 3, 2026
Sponsor: Shanghai Zhongshan Hospital
Multiple Myeloma · AL Amyloidosis
China
A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and Lenalidomide in Patients With Multiple Myeloma After Stem Cell Transplant Who Still Have Detectable DiseaseNot Yet Recruiting
NCT07740486Phase 3Updated Jul 31, 2026
Sponsor: Polish Myeloma Consortium
Multiple Myeloma (MM)
A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple MyelomaActive Not Recruiting
NCT07030517Phase 4Updated Jul 31, 2026
Sponsor: Johnson & Johnson Private Limited
Multiple Myeloma
India
Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 AlterationsNot Yet Recruiting
NCT07738887Phase 2Updated Jul 31, 2026
Sponsor: The Lymphoma Academic Research Organisation
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
Belgium, France
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell CarcinomaRecruiting
NCT07219212Phase 1Updated Jul 31, 2026
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Squamous Cell Carcinoma of Head and Neck
United States, France, Japan
A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)Recruiting
NCT07141004Phase 4Updated Jul 31, 2026
Sponsor: Johnson & Johnson Private Limited
Arthritis, Psoriatic
India
A Study of Varipulse Catheter in Participants With Paroxysmal Atrial Fibrillation Under Optimized SedationNot Yet Recruiting
NCT07511166N/AUpdated Jul 31, 2026
Sponsor: Johnson & Johnson Medical (Shanghai) Ltd.
Atrial Fibrillation
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCCRecruiting
NCT04892173Phase 3Updated Jul 31, 2026
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Carcinoma, Squamous Cell
United States, Austria, Belgium, Brazil, Bulgaria +22 more
The Study is an Observational Post-market Follow-up Program to Evaluate Long Term (5 Years) Safety of Mentor Breast Implants in Chinese PopulationRecruiting
NCT06510205N/AUpdated Jul 31, 2026
Sponsor: Johnson & Johnson Medical (Shanghai) Ltd.
Breast Augmentation · Mammaplasty
China
Integrating the Guardian Spatial Emanator Within AVENIR IINot Yet Recruiting
NCT07712263NAUpdated Jul 22, 2026
Sponsor: University of California, San Francisco
Malaria
Niger
Robotic-Assisted Versus Conventional Total Knee Arthroplasty With Virtual Home-Based RehabilitationNot Yet Recruiting
NCT07716267NAUpdated Jul 21, 2026
Sponsor: Mark Hurworth
Osteoarthritis, Knee
Non-Invasive Preeclampsia Screening and BiobankRecruiting
NCT06643741N/AUpdated Jul 20, 2026
Sponsor: Sequenom, Inc.
Preeclampsia (PE)
United States
Clinical Investigation of the TECNIS® Next-Generation Intraocular LensCompleted
NCT06377514NAUpdated Jul 17, 2026
Sponsor: Johnson & Johnson Surgical Vision, Inc.
Cataracts
United States
Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness LevelRecruiting
NCT07649525Phase 3Updated Jul 15, 2026
Sponsor: University of Leeds
Multiple Myeloma (MM) · Plasma Cell Leukemia (PCL)
United Kingdom
Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against EbolaCompleted
NCT04186000Phase 2Updated Jul 14, 2026
Sponsor: Universiteit Antwerpen
Ebola Virus Disease
Democratic Republic of the Congo
Cervical Plexus Hydrodissection With D5W for PTSDActive Not Recruiting
NCT04421573NAUpdated Jul 14, 2026
Sponsor: Dr. Dean Reeves Clinic
PTSD
United States
The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar DepressionNot Yet Recruiting
NCT07699445Phase 4Updated Jul 13, 2026
Sponsor: Massachusetts General Hospital
Bipolar Depression Depressed Phase · Obesity & Overweight
United States
RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EFNot Yet Recruiting
NCT07696975NAUpdated Jul 10, 2026
Sponsor: V-Wave Ltd
Heart Failure and Reduced Ejection Fraction · Heart Failure Chronic · Heart Failure New York Heart Association Class III · Heart Failure Congestive

1,540 studies found